Skip to main content
Ron Berghmans

    Ron Berghmans

    Research Interests:
    Search the BMJ. BMJ; BMJ Journals; BMJ Careers; BMJ Learning; Evidence Centre; doc2doc; BMJ Group. bmj.com. Search this site. Advanced search. Institution: Google Indexer; Sign in. Home; Research: Methods and Reporting. Education: ...
    Research Interests:
    Although this point is sometimes mis-understood by foreign commentators, physician-assisted suicide is a criminal offense in the Netherlands. Assisting in the suicide of a person, which includes providing the means for somebody else to... more
    Although this point is sometimes mis-understood by foreign commentators, physician-assisted suicide is a criminal offense in the Netherlands. Assisting in the suicide of a person, which includes providing the means for somebody else to take his life, is a crime under Article 294 of the ...
    Some of the views of the Royal Dutch Medical Association on end-of-life decisions in cases of people suffering from Alzheimer disease and related disorders are presented. The focus of the present report is on the views of the commission... more
    Some of the views of the Royal Dutch Medical Association on end-of-life decisions in cases of people suffering from Alzheimer disease and related disorders are presented. The focus of the present report is on the views of the commission regarding active life termination of demented patients with or without an actual and explicit request from the patient. Some comments on these views are made, particularly regarding the notion of "loss of human dignity" (ontluistering) with respect to dementia.
    Page 1. Chapter 24 Dementia and End-of-Life Decisions: Ethical Issues – A Perspective from The Netherlands Ron LP Berghmans Contents ...
    Advance directives are often regarded as instructions to the doctor about future care. This view is problematic, in that it obliterates that decisions about treatment and care always take place in a concrete situation, and require... more
    Advance directives are often regarded as instructions to the doctor about future care. This view is problematic, in that it obliterates that decisions about treatment and care always take place in a concrete situation, and require interpretation and communication. From a hermeneutic perspective, advance directives can be regarded as instruments which do not replace interpretation and communication, but sustain joint decision-making about treatment and care, including the patient and the family in a process of meaning-making.
    Page 1. EDITORIAL COMMENT Ethical Hazards of the Substituted Judgement Test in Decision Making Concerning the End of Life of Dementia Patients RON LP BERGHMANS Scientific Researcher, Institute for Bioethics, PO Box 778, 6200 AT... more
    Page 1. EDITORIAL COMMENT Ethical Hazards of the Substituted Judgement Test in Decision Making Concerning the End of Life of Dementia Patients RON LP BERGHMANS Scientific Researcher, Institute for Bioethics, PO Box 778, 6200 AT Maastricht, The Netherlands ...
    Advertisement. Current Opinion in Psychiatry. Wolters Kluwer Health Logo. All Issues. ...
    Phase 1 oncology trials involve risk and offer a relatively low prospect of benefit to participants. Some claim that participants constitute a vulnerable population requiring special protections. We undertook this study to determine... more
    Phase 1 oncology trials involve risk and offer a relatively low prospect of benefit to participants. Some claim that participants constitute a vulnerable population requiring special protections. We undertook this study to determine whether phase 1 oncology trial participants have demographic and health status characteristics of a vulnerable population. We reviewed participant demographic and health status data from phase 1 trials sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute that began between 1991 and 2002 and from 11 previously published studies. Main outcome measures were median age, sex, race/ethnicity, performance status, previous therapy, educational achievement level, and health insurance coverage. Almost 10 000 participants in trials sponsored by the Cancer Therapy Evaluation Program had a median age of 57 years, 90% self-identified as white, 93% had near-normal performance status, 85% had some form of health insurance, and 92% had been previously treated for cancer; 20 000 individuals from published studies had comparable profiles. The demographic and health status characteristics of phase 1 oncology trial participants are not those of a conventional vulnerable population and suggest little reason to assume that, as a group, they have a compromised ability to understand information or to make informed and voluntary decisions.
    RefDoc Bienvenue - Welcome. Refdoc est un service / is powered by. ...
    Respecting patient autonomy is an important value in (mental) health care. In many jurisdictions, this value is translated into the concept of informed consent, which implies that before treatment or research can take place, the patient... more
    Respecting patient autonomy is an important value in (mental) health care. In many jurisdictions, this value is translated into the concept of informed consent, which implies that before treatment or research can take place, the patient or research subject should give consent ...
    The shift in the prevailing view of alcoholism from a moral paradigm towards a biomedical paradigm is often characterized as a form of biomedicalization. We will examine and critique three reasons offered for the claim that viewing... more
    The shift in the prevailing view of alcoholism from a moral paradigm towards a biomedical paradigm is often characterized as a form of biomedicalization.
    We will examine and critique three reasons offered for the claim that viewing alcoholism as a disease is morally problematic. The first is that the new conceptualization of alcoholism as a chronic brain disease will lead to individualization, e.g., a too narrow focus on the individual person, excluding cultural and social
    dimensions of alcoholism. The second claim is that biomedicalization will lead to stigmatization and discrimination for both alcoholics and people who are at risk of becoming alcoholics. The third claim is that as a result of the biomedical point of view, the autonomy and responsibility of alcoholics and possibly even persons at risk may be unjustly restricted. Our conclusion is that the claims against the biomedical
    conceptualization of alcoholism as a chronic brain disease are neither specific nor convincing. Not only do some of these concerns also apply to the traditional moral model; above that they are not strong enough to justify the rejection of the new biomedical model altogether. The focus in the scientific and
    public debate should not be on some massive ‘‘biomedicalization objection’’ but on the various concerns underlying what is framed in terms of the biomedicalization of
    alcoholism.